Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/7860
Full metadata record
DC FieldValueLanguage
dc.contributor.authorErdem, H.-
dc.contributor.authorStahl, J.P.-
dc.contributor.authorInan, A.-
dc.contributor.authorKilic, S.-
dc.contributor.authorAkova, M.-
dc.contributor.authorRioux, C.-
dc.contributor.authorPierre, I.-
dc.date.accessioned2019-08-16T12:33:01Z-
dc.date.available2019-08-16T12:33:01Z-
dc.date.issued2014-
dc.identifier.issn0934-9723-
dc.identifier.urihttps://hdl.handle.net/11499/7860-
dc.identifier.urihttps://doi.org/10.1007/s10096-014-2116-9-
dc.description.abstractThe aim of this study was to assess the infectious diseases (ID) wards of tertiary hospitals in France and Turkey for technical capacity, infection control, characteristics of patients, infections, infecting organisms, and therapeutic approaches. This cross-sectional study was carried out on a single day on one of the weekdays of June 17-21, 2013. Overall, 36 ID departments from Turkey (n=21) and France (n=15) were involved. On the study day, 273 patients were hospitalized in Turkish and 324 patients were followed in French ID departments. The numbers of patients and beds in the hospitals, and presence of an intensive care unit (ICU) room in the ID ward was not different in both France and Turkey. Bed occupancy in the ID ward, single rooms, and negative pressure rooms were significantly higher in France. The presence of a laboratory inside the ID ward was more common in Turkish ID wards. The configuration of infection control committees, and their qualifications and surveillance types were quite similar in both countries. Although differences existed based on epidemiology, the distribution of infections were uniform on both sides. In Turkey, anti-Gram-positive agents, carbapenems, and tigecycline, and in France, cephalosporins, penicillins, aminoglycosides, and metronidazole were more frequently preferred. Enteric Gram-negatives and hepatitis B and C were more frequent in Turkey, while human immunodeficiency virus (HIV) and streptococci were more common in France (p<0.05 for all significances). Various differences and similarities existed in France and Turkey in the ID wards. However, the current scene is that ID are managed with high standards in both countries. © 2014 Springer-Verlag.en_US
dc.language.isoenen_US
dc.publisherSpringer Verlagen_US
dc.relation.ispartofEuropean Journal of Clinical Microbiology and Infectious Diseasesen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectaminoglycosideen_US
dc.subjectampicillinen_US
dc.subjectcarbapenem derivativeen_US
dc.subjectcephalosporin derivativeen_US
dc.subjectciprofloxacinen_US
dc.subjectcolistinen_US
dc.subjectcotrimoxazoleen_US
dc.subjectdoxycyclineen_US
dc.subjecthand sanitizeren_US
dc.subjectmetronidazoleen_US
dc.subjectpenicillin derivativeen_US
dc.subjectquinolone derivativeen_US
dc.subjectrifampicinen_US
dc.subjecttigecyclineen_US
dc.subjectantiinfective agenten_US
dc.subjectabscessen_US
dc.subjectAcinetobacter baumanniien_US
dc.subjectAggregatibacter actinomycetemcomitansen_US
dc.subjectantibiotic prophylaxisen_US
dc.subjectantimicrobial therapyen_US
dc.subjectarticleen_US
dc.subjectAspergillusen_US
dc.subjectBacillus cereusen_US
dc.subjectbacterial endocarditisen_US
dc.subjectbone infectionen_US
dc.subjectBrucellaen_US
dc.subjectbrucellosisen_US
dc.subjectCampylobacteren_US
dc.subjectCandidaen_US
dc.subjectcentral nervous system infectionen_US
dc.subjectcholangitisen_US
dc.subjectcholecystitisen_US
dc.subjectclinical practiceen_US
dc.subjectClostridiumen_US
dc.subjectcolitisen_US
dc.subjectCorynebacteriumen_US
dc.subjectCreutzfeldt Jakob diseaseen_US
dc.subjectCrimean Congo hemorrhagic feveren_US
dc.subjectcross-sectional studyen_US
dc.subjectCryptococcusen_US
dc.subjectcytomegalovirus infectionen_US
dc.subjectdiabetic footen_US
dc.subjectdisease severityen_US
dc.subjectdisease surveillanceen_US
dc.subjectEnterococcusen_US
dc.subjectEnterovirus infectionen_US
dc.subjectFranceen_US
dc.subjectgastroenteritisen_US
dc.subjectHaemophilusen_US
dc.subjecthealth care personnelen_US
dc.subjecthepatitis Ben_US
dc.subjecthepatitis Cen_US
dc.subjecthospital bed capacityen_US
dc.subjecthospital bed utilizationen_US
dc.subjecthospital hygieneen_US
dc.subjecthospital laboratoryen_US
dc.subjecthospital patienten_US
dc.subjecthospital wasteen_US
dc.subjecthospitalizationen_US
dc.subjecthumanen_US
dc.subjectHuman immunodeficiency virus infectionen_US
dc.subjectinfectionen_US
dc.subjectinfection controlen_US
dc.subjectinfection preventionen_US
dc.subjectinfectious arthritisen_US
dc.subjectinfectious diseases warden_US
dc.subjectintensive care uniten_US
dc.subjectLegionellaen_US
dc.subjectLeptospiraen_US
dc.subjectmajor clinical studyen_US
dc.subjectmalariaen_US
dc.subjectmeaslesen_US
dc.subjectMeasles virusen_US
dc.subjectMycobacterium intracellulare aviumen_US
dc.subjectMycobacterium tuberculosisen_US
dc.subjectNeisseriaen_US
dc.subjectnurseen_US
dc.subjectPlasmodium falciparumen_US
dc.subjectpneumoniaen_US
dc.subjectpriority journalen_US
dc.subjectprotective equipmenten_US
dc.subjectPseudomonas aeruginosaen_US
dc.subjectRNA virus infectionen_US
dc.subjectroom ventilationen_US
dc.subjectsepsisen_US
dc.subjectseptic shocken_US
dc.subjectskin infectionen_US
dc.subjectsoft tissue infectionen_US
dc.subjectStaphylococcus aureusen_US
dc.subjectStreptococcusen_US
dc.subjectStreptococcus infectionen_US
dc.subjectsurgical infectionen_US
dc.subjectsyphilisen_US
dc.subjecttertiary care centeren_US
dc.subjectTreponema pallidumen_US
dc.subjecttuberculosisen_US
dc.subjectTurkey (republic)en_US
dc.subjectupper respiratory tract infectionen_US
dc.subjecturinary tract infectionen_US
dc.subjectvaccinationen_US
dc.subjectvirus hepatitisen_US
dc.subjectwarden_US
dc.subjectwaste managementen_US
dc.subjectadulten_US
dc.subjectageden_US
dc.subjectCommunicable Diseasesen_US
dc.subjectfemaleen_US
dc.subjectmaleen_US
dc.subjectmiddle ageden_US
dc.subjectpatient careen_US
dc.subjectproceduresen_US
dc.subjectstandardsen_US
dc.subjectTurkeyen_US
dc.subjectAdulten_US
dc.subjectAgeden_US
dc.subjectAnti-Bacterial Agentsen_US
dc.subjectCross-Sectional Studiesen_US
dc.subjectFemaleen_US
dc.subjectHumansen_US
dc.subjectInfection Controlen_US
dc.subjectMaleen_US
dc.subjectMiddle Ageden_US
dc.subjectPatient Careen_US
dc.subjectTertiary Care Centersen_US
dc.titleThe features of infectious diseases departments and anti-infective practices in France and Turkey: A cross-sectional studyen_US
dc.typeArticleen_US
dc.identifier.volume33en_US
dc.identifier.issue9en_US
dc.identifier.startpage1591
dc.identifier.startpage1591en_US
dc.identifier.endpage1599en_US
dc.identifier.doi10.1007/s10096-014-2116-9-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.pmid24789652en_US
dc.identifier.scopus2-s2.0-84906062372en_US
dc.identifier.wosWOS:000340538700017en_US
dc.identifier.scopusqualityQ1-
dc.ownerPamukkale University-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeArticle-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.grantfulltextnone-
item.cerifentitytypePublications-
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

3
checked on Nov 16, 2024

WEB OF SCIENCETM
Citations

3
checked on Nov 21, 2024

Page view(s)

28
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.